 * [1. Sensitivity Analysis](#1-sensitivity-analysis)




# 1. Sensitivity Analysis


Figure 1: Sensitivity of C_max of op1 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/C_max_Organism-VenousBlood-Plasma-Raltegravir-Concentration.png)


Figure 2: Sensitivity of t_max of op1 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/t_max_Organism-VenousBlood-Plasma-Raltegravir-Concentration.png)


Figure 3: Sensitivity of C_tEnd of op1 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/C_tEnd_Organism-VenousBlood-Plasma-Raltegravir-Concentration.png)


Figure 4: Sensitivity of AUC_tEnd of op1 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/AUC_tEnd_Organism-VenousBlood-Plasma-Raltegravir-Concentration.png)


Figure 5: Sensitivity of AUC_inf of op1 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/AUC_inf_Organism-VenousBlood-Plasma-Raltegravir-Concentration.png)


Figure 6: Sensitivity of MRT of op1 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/MRT_Organism-VenousBlood-Plasma-Raltegravir-Concentration.png)


Figure 7: Sensitivity of Thalf of op1 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/Thalf_Organism-VenousBlood-Plasma-Raltegravir-Concentration.png)


Figure 8: Sensitivity of FractionAucLastToInf of op1 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/FractionAucLastToInf_Organism-VenousBlood-Plasma-Raltegravir-Concentration.png)


Figure 9: Sensitivity of CL of op1 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/CL_Organism-VenousBlood-Plasma-Raltegravir-Concentration.png)


Figure 10: Sensitivity of Vss of op1 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/Vss_Organism-VenousBlood-Plasma-Raltegravir-Concentration.png)


Figure 11: Sensitivity of Vd of op1 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/Vd_Organism-VenousBlood-Plasma-Raltegravir-Concentration.png)


Figure 12: Sensitivity of new_t_max of op2 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/t_max_Organism-ArterialBlood-Plasma-Raltegravir-Concentration.png)


Figure 13: Sensitivity of new_AUC_tEnd of op2 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral'.


![](Sensitivity/AUC_tEnd_Organism-ArterialBlood-Plasma-Raltegravir-Concentration.png)


Figure 14: Sensitivity of new_C_max of op3 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'lar', 'ral'.


![](Sensitivity/C_max_Organism-Lung-Interstitial-Raltegravir-Concentration.png)


Figure 15: Sensitivity of new_MRT of op3 for individuals at percentiles 0.25, 0.5, 0.75 in simulation sets 'ral', 'lar'.


![](Sensitivity/MRT_Organism-Lung-Interstitial-Raltegravir-Concentration.png)


